Cost effectiveness of treatments for relapsed/refractory...

Cost effectiveness of treatments for relapsed/refractory multiple myeloma: response to a methodology : RE: Hornberger J, Rickert J, Dhawan R, Liwing J, Aschan J, Löthgren M. The cost effectiveness of bortezomib in relapsed/refractory multiple myeloma: Swedish perspective. European Journal of Haematology 2010; 85 (6):484–491.

Jack Ishak, Filipe Rodrigues
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
87
Year:
2011
Language:
english
Pages:
1
DOI:
10.1111/j.1600-0609.2011.01624.x
File:
PDF, 49 KB
english, 2011
Conversion to is in progress
Conversion to is failed